The brain is often referred to as a 'black box'-- one that's difficult to peer inside and determine what's happening at any given moment. This is part of the reason why it's difficult to understand the complex interplay of molecules, cells and genes that underlie neurological disorders. But a new CRISPR screen method has the potential to uncover new therapeutic targets and treatments for these conditions.